Table 5

Self-reported health conditions and risk of rheumatoid arthritis, Denmark 1998 to 2003


Women
Men
Both genders





Number of patients/controls
ORa (95% CI)
Number of patients/controls
ORa (95% CI)
ORa (95% CI)

Mononucleosis
12/24
0.74 (0.35 to 1.56)
3/12
0.48 (0.13 to 1.84)
0.63 (0.33 to 1.20)b
Hay feverc
61/63
1.32 (0.89 to 1.97)
14/36
0.56 (0.27 to 1.17)
1.13 (0.81 to 1.58)
Atopic dermatitis
19/24
0.99 (0.51 to 1.90)
7/10
1.46 (0.51 to 4.20)
1.12 (0.65 to 1.94)
Asthmac,d
24/40
0.74 (0.43 to 1.28)
4/28
0.22 (0.07 to 0.67)
0.58 (0.36 to 0.93)e
Stomach or duodenal ulcer
20/32
0.70 (0.38 to 1.27)
12/30
0.70 (0.33 to 1.47)
0.73 (0.47 to 1.16)b
Diarrhea
49/84
0.72 (0.48 to 1.07)
27/53
1.01 (0.58 to 1.75)
0.81 (0.59 to 1.12)
Type I diabetesc
2/1
2.84 (0.22 to 36.05)
3/6
1.15 (0.26 to 5.00)
1.30 (0.39 to 4.34)
Thyroid diseasec
38/34
1.45 (0.87 to 2.40)
3/2
2.32 (0.35 to 15.44)
1.52 (0.94 to 2.46)b
Periodontal disease
83/118
0.95 (0.67 to 1.33)
41/88
0.92 (0.57 to 1.47)
0.91 (0.70 to 1.19)
Urinary tract infection
171/256
0.76 (0.57 to 1.01)
13/40
0.57 (0.28 to 1.14)
0.73 (0.57 to 0.95)e
Cancer
12/19
0.70 (0.33 to 1.49)
4/2
5.51 (0.89 to 34.19)
1.01 (0.51 to 1.99)
Blood transfusion
51/66
0.99 (0.65 to 1.51)
12/26
0.84 (0.39 to 1.79)
0.98 (0.68 to 1.40)
Tonsillectomy, adenoidectomy, appendectomy, or splenectomy
163/214
0.97 (0.73 to 1.29)
63/124
1.00 (0.65 to 1.55)
0.98 (0.78 to 1.24)
Schizophrenia among first-degree relatives
6/5
2.19 (0.62 to 7.77)
6/6
1.77 (0.51 to 6.11)
2.08 (0.88 to 4.93)b

Numbers of patients and controls refer to participants who ever had the health condition in question. aORs represent comparisons between 'ever' versus 'never' (= reference) for each presented disease, with adjustment for birth year, year or pseudo-year of RA diagnosis, and (when combined) gender. bTest for homogeneity 0.05 < p < 0.20. cPhysician-verified diagnosis. dAsthma before age 45 years. eTest for homogeneity p < 0.05. CI, confidence interval; OR, odds ratio.

Pedersen et al. Arthritis Research & Therapy 2006 8:R133   doi:10.1186/ar2022